This statement will be presented on Sept. 3 in a session on personalized medicine at the annual congress of the European Society of Cardiology in Amsterdam.
Dr. Kirchhof said that he has received consulting fees or honoraria from 16 different drug companies and device manufacturers. His complete disclosure statement as well as disclosures from the other task force members are listed in the statement document.
On Twitter @mitchelzoler